$KITE Form 8-K



Form 8-K for KITE PHARMA, INC.


Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.On October 20, 2015, Kite Pharma, Inc. (“Kite”) issued a press release announcing that it has entered into a

patent license agreement (the “License”) with the National Institutes of Health (“NIH”). Pursuant to the License, Kite holds an exclusive, worldwide license to certain intellectual property related to T cell receptor-based product candidates that target MAGE A3 and A3/A6 antigens. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.


Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

The following exhibit is filed as part of this Current Report:

99.1 Press Release of Kite issued October 20, 2015.


Please enter your comment!
Please enter your name here